Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Approvals Analysis: Strong Q3 For Metabolic-Disease Devices

Oct 07 2016

• By David Filmore

FDA approved background, 3D rendering, blue street sign

Related Content

Successful De Novo Petitions Double With Advent Of Direct Route

Oct 28 2014

FDA Hits User-Fee-Era Record For 'Novel' Devices: A New Normal?

Jan 14 2016

Abbott Gains US Approval For Pro Version Of Flash Glucose System

Sep 28 2016

US FDA Approves First 'Artificial Pancreas' In Medtronic's MiniMed 670G

Sep 28 2016

Obesity 2016: Minimally Invasive Bariatric Devices Gaining Steam

Jul 20 2016

Related Companies

Obalon Therapeutics Inc.

Apollo Endosurgery, Inc.

Medtronic plc

Abbott

Roche Holding AG

Johnson & Johnson

Stryker Corporation

Additional Topics

United States Research & Development Approvals Innovation Regulation Medical Device In Vitro Diagnostics

More from R&D

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window